Get the Stockscreener App
3.63
0.00%
+0.00
Eton Pharmaceuticals Inc Stock (ETON) Forecast
The Eton Pharmaceuticals Inc (ETON) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.1137, representing a -14.22% decrease from the current price of $3.63. The highest analyst price target is $3.8038, and the lowest is $2.4236.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ETON Price Target
Average 2.3004
(-36.63% Downside)
Is Eton Pharmaceuticals Inc (ETON) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.51 | Neutral |
| STOCH(9,6) | 45.66 | Neutral |
| STOCHRSI(14) | 76.54 | Neutral |
| MACD(12,26) | 0.0113 | Buy |
| ADX(14) | 16.16 | Neutral |
| William %R | -29.06 | Neutral |
| CCI(14) | 33.68 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.6391
Buy
|
3.5905
Buy
|
| MA20 |
3.4826
Buy
|
3.5592
Buy
|
| MA50 |
3.6626
Buy
|
3.6854
Buy
|
| MA100 |
4.085
Sell
|
3.8617
Sell
|
| MA200 |
4.0795
Sell
|
3.9069
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ETON could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on ETON, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.51 indicates that ETON is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.66 indicates that ETON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 76.54 indicates that ETON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.16 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 33.68 indicates that ETON is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ETON price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eton Pharmaceuticals Inc financial reports and earnings history, Eton Pharmaceuticals Inc (ETON) stock could reach $1.2434 by 2030, $3.9264 by 2040 and $11.71 by 2050. See the projected annual prices until 2050 of the Eton Pharmaceuticals Inc stock below:
- Eton Pharmaceuticals Inc (ETON) is expected to reach an average price of $0.763 in 2035, with a high prediction of $0.733 and a low estimate of $0.4613. This indicates an $-78.98% rise from the last recorded price of $3.63.
- Eton Pharmaceuticals Inc (ETON) stock is projected to chart a bullish course in 2040, with an average price target of $3.9947, representing an $10.05% surge from its current level. The forecast ranges from a conservative $4.1502 to a sky-high $3.9264.
- Our analysts predict Eton Pharmaceuticals Inc (ETON) to jump 148.57% by 2045, soaring from $9.243 to an average price of $9.023, potentially reaching $9.0901. While $9.243 is the low estimate, the potential upside is significant.
- Eton Pharmaceuticals Inc (ETON) stock is expected to climb by 2050, reaching an average of $11.26, a $210.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.71 and $11.72, respectively, highlighting the market's uncertainty.
Eton Pharmaceuticals Inc Stock (ETON) Year by Year Forecast
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2024
Our forecast for ETON stock price in 2024 now indicates an average price target of $3.2496 with a high forecast of $5.7217 and a low forecast of $0.7774. The average prediction reflects an decrease of -10.48% from the last recorded price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.438 | $2.4236 | $3.8038 | -5.29% |
| July, 2024 | $1.7439 | $1.6755 | $4.5888 | -51.96% |
| August, 2024 | $1.3474 | $0.7774 | $2.3223 | -62.88% |
| September, 2024 | $2.941 | $0.7942 | $3.071 | -18.98% |
| October, 2024 | $1.8229 | $1.3738 | $2.9094 | -49.78% |
| November, 2024 | $1.5764 | $1.3413 | $2.6513 | -56.57% |
| December, 2024 | $1.805 | $1.2048 | $2.25 | -50.28% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2025
Eton Pharmaceuticals Inc Stock (ETON) is expected to reach an average price of $2.6539 in 2025, with a high prediction of $5.2956 and a low estimate of $0.0121. This indicates an -26.89% fall from the last recorded price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.2019 | $1.7284 | $3.4047 | -11.79% |
| February, 2025 | $2.5454 | $2.1854 | $3.3787 | -29.88% |
| March, 2025 | $1.249 | $1.049 | $3.3906 | -65.59% |
| April, 2025 | $0.0909 | $0.1791 | $1.9074 | -97.50% |
| May, 2025 | $0.2244 | $0.0121 | $0.466 | -93.82% |
| June, 2025 | $0.758 | $0.333 | $1.7896 | -79.12% |
| July, 2025 | $1.9299 | $0.4047 | $2.1299 | -46.84% |
| August, 2025 | $1.1334 | $0.9334 | $2.5583 | -68.78% |
| September, 2025 | $2.757 | $0.8918 | $3.267 | -24.05% |
| October, 2025 | $3.4189 | $2.1253 | $4.8653 | -5.82% |
| November, 2025 | $4.0924 | $2.9373 | $5.2956 | +12.74% |
| December, 2025 | $3.5243 | $2.8392 | $4.666 | -2.91% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2026
The predicted value for Eton Pharmaceuticals Inc (ETON) in 2026 is set at an average of $3.6551. Estimates vary from a peak of $6.6685 to a trough of $0.6416, indicating an +0.69% surge from the present price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.2179 | $2.7811 | $4.3179 | +16.19% |
| February, 2026 | $4.9114 | $3.9446 | $5.3914 | +35.30% |
| March, 2026 | $5.4049 | $4.0628 | $5.7181 | +48.90% |
| April, 2026 | $6.0669 | $4.6944 | $6.6685 | +67.13% |
| May, 2026 | $4.4004 | $3.4236 | $6.0153 | +21.22% |
| June, 2026 | $3.9439 | $3.1611 | $4.6188 | +8.65% |
| July, 2026 | $4.7359 | $3.6023 | $5.3099 | +30.46% |
| August, 2026 | $3.3094 | $2.271 | $5.4026 | -8.83% |
| September, 2026 | $2.4613 | $2.0713 | $4.8778 | -32.20% |
| October, 2026 | $2.4249 | $1.7065 | $2.6749 | -33.20% |
| November, 2026 | $1.8984 | $0.6416 | $2.0084 | -47.70% |
| December, 2026 | $1.7303 | $1.4535 | $1.9868 | -52.33% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eton Pharmaceuticals Inc (ETON) is $1.7348, with a high forecast of $3.4406 and a low forecast of $0.0289. This indicates an -52.21% decrease from the last price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2339 | $1.4121 | $2.3638 | -38.46% |
| February, 2027 | $1.2974 | $1.0474 | $3.4406 | -64.26% |
| March, 2027 | $0.9093 | $0.3025 | $1.2958 | -74.95% |
| April, 2027 | $0.8428 | $0.6928 | $1.5844 | -76.78% |
| May, 2027 | $0.5964 | $0.1604 | $0.8212 | -83.57% |
| June, 2027 | $0.7683 | $0.2715 | $0.9148 | -78.83% |
| July, 2027 | $1.2818 | $0.4467 | $1.3635 | -64.69% |
| August, 2027 | $0.7454 | $0.517 | $1.447 | -79.47% |
| September, 2027 | $0.1673 | $0.0289 | $0.8038 | -95.39% |
| October, 2027 | $0.0392 | $0.1159 | $0.2541 | -98.92% |
| November, 2027 | $0.1056 | $0.1208 | $0.264 | -97.09% |
| December, 2027 | $0.0163 | $0.1437 | $0.3311 | -99.55% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2028
In 2028, Eton Pharmaceuticals Inc (ETON) is projected to reach an average price of $0.8947, with a high projection of $1.7803 and a low estimate of $0.00913. This indicates an -75.35% fall from the last price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5402 | $0.5753 | $0.5352 | -85.12% |
| February, 2028 | $0.7266 | $0.6418 | $0.5866 | -79.98% |
| March, 2028 | $0.2347 | $0.2631 | $0.5599 | -93.53% |
| April, 2028 | $0.2388 | $0.0296 | $0.3803 | -93.42% |
| May, 2028 | $0.3407 | $0.0114 | $0.644 | -90.61% |
| June, 2028 | $0.7443 | $0.00913 | $1.1743 | -79.50% |
| July, 2028 | $0.7678 | $0.5494 | $1.1427 | -78.85% |
| August, 2028 | $1.2697 | $0.6162 | $1.3897 | -65.02% |
| September, 2028 | $0.9833 | $0.9833 | $1.6581 | -72.91% |
| October, 2028 | $1.0668 | $0.8384 | $1.3068 | -70.61% |
| November, 2028 | $1.3887 | $0.8252 | $1.7803 | -61.74% |
| December, 2028 | $1.0323 | $0.6923 | $1.5939 | -71.56% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2029
The 2029 price forecast for Eton Pharmaceuticals Inc Stock (ETON) is $1.7327 on average, with a high prediction of $3.4613 and a low estimate of $0.00419. This represents an -52.27% decrease from the previous price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4042 | $0.00419 | $1.2207 | -88.87% |
| February, 2029 | $2.4877 | $0.071 | $2.9677 | -31.47% |
| March, 2029 | $2.6013 | $1.6629 | $3.4613 | -28.34% |
| April, 2029 | $1.6048 | $1.4022 | $2.7596 | -55.79% |
| May, 2029 | $1.5667 | $1.3515 | $2.3467 | -56.84% |
| June, 2029 | $1.4603 | $1.1335 | $1.6019 | -59.77% |
| July, 2029 | $2.1738 | $1.3086 | $2.6338 | -40.12% |
| August, 2029 | $2.5057 | $1.7889 | $2.9203 | -30.97% |
| September, 2029 | $2.3393 | $2.0193 | $2.6025 | -35.56% |
| October, 2029 | $1.8712 | $1.2412 | $2.5228 | -48.45% |
| November, 2029 | $1.1347 | $0.9747 | $2.0279 | -68.74% |
| December, 2029 | $0.8067 | $1.0631 | $1.7399 | -77.78% |
Eton Pharmaceuticals Inc Stock (ETON) Price Forecast for 2030
Eton Pharmaceuticals Inc Stock (ETON) is expected to reach an average price of $2.7674 in 2030, with a high forecast of $4.5518 and a low forecast of $0.9831. This signifies an -23.76% decrease from the last price of $3.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0282 | $0.9831 | $1.2434 | -71.68% |
| February, 2030 | $0.4869 | $1.2225 | $0.8679 | -86.59% |
| March, 2030 | $2.2654 | $2.2957 | $2.2622 | -37.59% |
| April, 2030 | $3.1383 | $2.8686 | $2.7183 | -13.54% |
| May, 2030 | $2.4445 | $2.4213 | $3.1016 | -32.66% |
| June, 2030 | $2.7174 | $2.7042 | $2.0877 | -25.14% |
| July, 2030 | $2.2936 | $2.6039 | $2.5039 | -36.82% |
| August, 2030 | $1.5665 | $2.2065 | $1.9968 | -56.85% |
| September, 2030 | $0.8194 | $1.2594 | $1.1697 | -77.43% |
| October, 2030 | $1.2056 | $1.2227 | $1.2324 | -66.79% |
| November, 2030 | $4.3085 | $2.1423 | $2.9685 | +18.69% |
| December, 2030 | $4.6314 | $4.2382 | $4.5518 | +27.59% |
2.17%
1.10%
Cap:
|
Volume (24h):